Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism DSGN Q1 2026 Earnings NarrowerthanExpected Loss Despite No Revenue AVNT Q1 2026 Earnings Slight EPS Beat Fails to Inspire Market CIA Q1 2026 Earnings EPS Miss Triggers Cautious Market Response GD Q1 2026 Earnings Strong Earnings Beat Driven by Aerospace and Defense Momentum Camden National Corporation CAC Q1 2026 Earnings EPS Beats Estimates Amid Net Interest Margin Pressure Stock Edges Lower